Global Carbamazepine (CBZ) Market Outlook 2017-2022

Publisher Name :
Date: 10-Mar-2017
No. of pages: 106

Carbamazepine (CBZ), sold under the tradename Tegretol among others, is a medication used primarily in the treatment of epilepsy and neuropathic pain. For seizures it works as well as phenytoin and valproate. It is not effective for absence seizures or myoclonic seizures. It may be used in schizophrenia along with other medications and as a second line agent in bipolar disorder.

This report provides detailed analysis of worldwide markets for Carbamazepine (CBZ) from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the volumes, prices, historical growth and future perspectives in the Carbamazepine (CBZ) market and further lays out an analysis of the factors influencing the supply/demand for Carbamazepine (CBZ), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Carbamazepine (CBZ) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Carbamazepine (CBZ) market are TEVA (Israel), TARO (Israel), Jubilant Pharma (India), Zhejiang Jiuzhou (China), Jinan Jinda (China), Sihuan Shengwu (China), Jiangsu Tohope (China), Shanghai Modern Hasen (China) etc.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Carbamazepine (CBZ) industry has been provided.

Global Carbamazepine (CBZ) Market Outlook 2017-2022

Table of Contents

Part 1. Exclusive Summary

Part 2. Methodology
2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

Part 3. Introduction
3.1 Carbamazepine (CBZ) Definition
3.2 Supply Chain Structure
3.2.1 Raw Material Supply
3.2.2 Manufacturing
3.2.3 Production Cost Analysis

Part 4. Market Landscape
4.1 Global Carbamazepine (CBZ) Market by Volume 2011-2016
4.1.1 Overview
4.1.2 Global Carbamazepine (CBZ) Volume 2011-2016
4.1.3 Top 10 Carbamazepine (CBZ) Companies (Volume Share)
4.2 Global Carbamazepine (CBZ) Revenue 2011-2016
4.2.1 Overview
4.2.2 Global Carbamazepine (CBZ) Market by Revenue 2011-2016
4.2.3 Top 10 Carbamazepine (CBZ) Companies (Revenue Share)

Part 5. Segmentation by Type
5.1 Type 1
5.2 Type 2
5.3 Type 3

Part 6. Segmentation by Application
6.1 Application 1
6.2 Application 2
6.3 Application 3
6.4 Application 4

Part 7. North America Carbamazepine (CBZ) Market
7.1 North America Carbamazepine (CBZ) Market Size
7.2 Price & Margin
7.3 Trade Balance

Part 8. Europe Carbamazepine (CBZ) Market
8.1 Europe Market Carbamazepine (CBZ) Size
8.2 Price & Margin
8.3 Trade Balance

Part 9. Asia Pacific Carbamazepine (CBZ) Market
9.1 Asia Pacific Carbamazepine (CBZ) Market Size
9.2 Price & Margin
9.3 Trade Balance

Part 10. Market Forecast
10.1 Market Size by Volume 2016-2021
10.1.1 North America
10.1.2 Europe
10.1.3 Asia-Pacific
10.1.4 RoW
10.2 Market Size by Revenue 2016-2021
10.2.1 North America
10.2.2 Europe
10.2.3 Asia-Pacific
10.2.4 RoW
10.3 Regional Consumption 2016-2021
10.3.1 North America
10.3.2 Europe
10.3.3 Asia-Pacific
10.3.4 RoW
10.4 Market by Type 2016-2021
10.5 Market by Application 2016-2021

Part 11. Company Profiles
11.1 Company A
11.1.1 Overview
11.1.2 Products Offered
11.1.3 Business Performance (Volume, Price, Revenue, Market Share)
11.2 Company B
11.3 Company C
11.4 Company D


Part 12. Market Dynamics
12.1 Market Drivers
12.2 Market Challenges
12.3 Market Trends
12.4 Market Events

Part 13. Appendix
13.1 Abbreviations
13.2 Disclaimer
13.3 Analysts Certification

List of Figures and Tables

Figure Global Carbamazepine (CBZ) Volume 2011-2016
Figure Global Carbamazepine (CBZ) Revenue (M USD) 2011-2016
Figure Global Carbamazepine (CBZ) Market by Company Share 2016
Figure Global Carbamazepine (CBZ) Market Volume by Region 2016
Figure Global Carbamazepine (CBZ) Market Revenue by Region (M USD) 2016
Figure Global Carbamazepine (CBZ) Market by Application 2016
Figure Global Carbamazepine (CBZ) Market by Product 2016
Figure Carbamazepine (CBZ) Product
Figure Carbamazepine (CBZ) Supply Chain Structure Analysis
Table Raw Materials Used for Carbamazepine (CBZ) Production
Figure Carbamazepine (CBZ) Manufacturing Process Flow
Figure Global Carbamazepine (CBZ) Market by Volume, Growth Rate 2011-2016
Table Global Carbamazepine (CBZ) Market by Volume, by Company 2011-2016
Table Global Carbamazepine (CBZ) Market by Volume Share, by Company 2011-2016
Figure Top 5 Companies Volume Share 2011-2016
Table Global Top 5 Companies by Volume Share 2011
Table Global Top 5 Companies by Volume Share 2012
Table Global Top 5 Companies by Volume Share 2013
Table Global Top 5 Companies by Volume Share 2014
Table Global Top 5 Companies by Volume Share 2015
Table Global Top 5 Companies by Volume Share 2016
Figure Global Carbamazepine (CBZ) Market by Revenue, Growth Rate & CAGR 2011-2016
Table Global Carbamazepine (CBZ) Market by Revenue, by Company 2011-2016
Table Global Carbamazepine (CBZ) Market by Revenue Share, by Company 2011-2016
Figure Top 5 Companies Revenue Share 2011-2016
Table Global Top 5 Companies by Revenue Share 2011
Table Global Top 5 Companies by Revenue Share) 2012
Table Global Top 5 Companies by Revenue Share 2013
Table Global Top 5 Companies by Revenue Share) 2014
Table Global Top 5 Companies by Revenue Share 2015
Table Global Top 5 Companies by Revenue Share 2016
Figure Global Carbamazepine (CBZ) Market by Type 2016
Table Type 1 Carbamazepine (CBZ) Volume 2011-2016
Table Type 1 Carbamazepine (CBZ) Price Trends 2011-2016
Table Type 2 Carbamazepine (CBZ) Volume 2011-2016
Table Type 2 Carbamazepine (CBZ) Price Trends 2011-2016
Table Type 3 Carbamazepine (CBZ) Volume 2011-2016
Table Type 3 Carbamazepine (CBZ) Price Trends 2011-2016
Figure Global Carbamazepine (CBZ) Market by Application 2016
Table Carbamazepine (CBZ) Consumed for Application A 2011-2016
Table Carbamazepine (CBZ) Consumed for Application B 2011-2016
Table Carbamazepine (CBZ) Consumed for Application C 2011-2016
Figure Global Carbamazepine (CBZ) Market Segmentation by Geography 2016
Figure North American Carbamazepine (CBZ) Volume 2011-2016
Figure North American Carbamazepine (CBZ) Revenue (M USD) 2011-2016
Figure North American Carbamazepine (CBZ) Price & Margin 2011-2016
Table North American Carbamazepine (CBZ) Trade Balance
Figure European Carbamazepine (CBZ) Volume 2011-2016
Figure European Carbamazepine (CBZ) Revenue (M USD) 2011-2016
Figure European Carbamazepine (CBZ) Price & Margin 2011-2016
Table European Carbamazepine (CBZ) Trade Balance
Figure Asia Pacific Carbamazepine (CBZ) Volume 2011-2016
Figure Asia Pacific Carbamazepine (CBZ) Revenue (M USD) 2011-2016
Figure Asia Pacific Carbamazepine (CBZ) Price & Margin 2011-2016
Table Asia Pacific Carbamazepine (CBZ) Trade Balance
Figure Global Carbamazepine (CBZ) Volume 2016-2021
Table Global Carbamazepine (CBZ) Volume Share 2016-2021
Figure North American Carbamazepine (CBZ) Volume 2016-2021
Figure European Carbamazepine (CBZ) Volume 2016-2021
Figure Asia-Pacific Carbamazepine (CBZ) Volume 2016-2021
Figure Global Carbamazepine (CBZ) Revenue (M USD) 2016-2021
Table Global Carbamazepine (CBZ) Revenue Share 2016-2021
Figure North American Carbamazepine (CBZ) Revenue (M USD) 2016-2021
Figure European Carbamazepine (CBZ) Revenue (M USD) 2016-2021
Figure Asia-Pacific Carbamazepine (CBZ) Revenue (M USD) 2016-2021
Figure Global Carbamazepine (CBZ) Consumption by Region 2021
Table Global Carbamazepine (CBZ) Consumption by Region 2016-2021
Table Global Carbamazepine (CBZ) Consumption Share by Region 2016-2021
Figure North American Carbamazepine (CBZ) Consumption 2016-2021
Figure European Carbamazepine (CBZ) Consumption 2016-2021
Figure Asia-Pacific Carbamazepine (CBZ) Consumption 2016-2021
Figure Global Carbamazepine (CBZ) Market by Application 2021
Table Global Carbamazepine (CBZ) Market by Application 2016-2021 (Volume)
Table Global Carbamazepine (CBZ) Market by Application 2016-2021 (Share)
Figure Global Carbamazepine (CBZ) Market by Type 2021
Table Global Carbamazepine (CBZ) Market by Type 2016-2021
Table Global Carbamazepine (CBZ) Market Share by Type 2016-2021
Table Company A Financial Performance 2011-2016
Figure Company A Market Share Trend 2011-2016
Table Company B Financial Performance 2011-2016
Figure Company B Market Share Trend 2011-2016
Table Company C Financial Performance 2011-2016
Figure Company C Market Share Trend 2011-2016
Table Company D Financial Performance 2011-2016
Figure Company D Market Share Trend 2011-2016
Table Company E Financial Performance 2011-2016
Figure Company E Market Share Trend 2011-2016
Table Company F Financial Performance 2011-2016
Figure Company F Market Share Trend 2011-2016
  • Global Narcolepsy Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80
    According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......
  • Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......
  • Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......
  • Migraine Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......
  • Global Edaravone Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......
  • Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......
  • Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs